ACTU
ACTUATE THERAPEUTICS, INC.Company Information
- Company Name
- ACTUATE THERAPEUTICS, INC.
- CIK
- CIK0001652935
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ACTU: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ACTU
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-27
- Last sale
- 2026-01-05
- Shares purchased (TTM)
- 214,284
- Shares sold (TTM)
- 280,000
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 13,856,355
- Shares outstanding
- 23,537,134
- Ownership
- 58.87%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 46.53%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||
| Cash Equivalents At Carrying Value | 4 | 8 | 13 | 17 | 6 | 4 | 9 | 14 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | ||||||
| Assets Current | 5 | 9 | 14 | 17 | 7 | 4 | 9 | 14 | 1 | ||||||
| Deferred Costs | - | - | - | - | - | - | - | - | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Assets | 5 | 9 | 14 | 18 | 7 | 4 | 9 | 14 | 2 | ||||||
Liabilities Current | |||||||||||||||
| Accounts Payable Current | 1 | 1 | 2 | 1 | 3 | 3 | 2 | 2 | 6 | ||||||
| Other Accrued Liabilities Current | 2 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 7 | ||||||
| Accrued Salaries Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 4 | 5 | 6 | 6 | 9 | 9 | 9 | 8 | 20 | ||||||
Liabilities Noncurrent | |||||||||||||||
| Other Accrued Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 1 | ||||||
| Interest Payable Current And Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Other Current And Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | ||||||
| Liabilities | 4 | 5 | 6 | 7 | 10 | 10 | 9 | 9 | 22 | ||||||
Stockholders Equity | |||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | 0 | 94 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 166 | 164 | 163 | 161 | 142 | 134 | 132 | 131 | 6 | ||||||
| Retained Earnings Accumulated Deficit | -165 | -160 | -155 | -150 | -145 | -139 | -132 | -126 | -120 | ||||||
| Stockholders Equity | 1 | 4 | 8 | 11 | -3 | -5 | 0 | 5 | -114 | ||||||
| Liabilities And Stockholders Equity | 5 | 9 | 14 | 18 | 7 | 4 | 9 | 14 | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 0 | 0 | 33 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | 0 | 25 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 38 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 25 | ||||||
| Common Stock Shares Issued | 24 | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 2 | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | 0 | 0 | 125 | ||||||
| Shares Outstanding | 24 | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 2 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialACTUATE THERAPEUTICS, INC. (ACTU) — SEC Financial Statements & Analysis
ACTUATE THERAPEUTICS, INC. (ACTU) is a pharmaceutical preparations company, incorporated in DE. ACTUATE THERAPEUTICS, INC. trades on Nasdaq as: ACTU. ACTUATE THERAPEUTICS, INC. (ACTU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, ACTUATE THERAPEUTICS, INC. carries a market cap of $36.52M, a P/E ratio of -1.79x, a P/B ratio of 36.92x, an enterprise value of $32.10M, and an EV/EBITDA multiple of -1.55x. On profitability, it posts a Return on Equity (ROE) of 2457.58% and a Return on Assets (ROA) of -336.18%. Per share, it reports EPS of $-0.86, diluted EPS of $-0.86, free cash flow per share of $-0.83, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -37.98% year-over-year and EPS growth of -48.96% year-over-year. On the balance sheet, it maintains a current ratio of 1.25x, a quick ratio of 1.16x, working capital of $942.75K, a debt-to-equity ratio of 4.26x, a debt ratio of 0.81, an interest coverage ratio of -1025.85x, free cash flow of $-19.84M (TTM), and net debt of $-4.43M. Figures sourced from SEC EDGAR.
- Market Cap
- $36.52M
- P/E TTM
- -1.79x
- EPS TTM
- $-0.86
- P/B TTM
- 36.92x
- ROE TTM
- 2457.58%
- ROA TTM
- -336.18%
- Debt To Equity
- 4.26x
- Free Cash Flow TTM
- $-19.84M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ACTUATE THERAPEUTICS, INC. in?
ACTUATE THERAPEUTICS, INC. (ACTU) operates in the Pharmaceutical Preparations industry.
What exchange does ACTU trade on?
ACTUATE THERAPEUTICS, INC. (ACTU) trades on the Nasdaq.
Where is ACTUATE THERAPEUTICS, INC. incorporated?
ACTUATE THERAPEUTICS, INC. is incorporated in DE.
When was ACTUATE THERAPEUTICS, INC. (ACTU)'s most recent SEC filing?
ACTUATE THERAPEUTICS, INC. (ACTU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ACTU's market cap?
ACTUATE THERAPEUTICS, INC. (ACTU) has a market capitalization of $36.52M as of 2026-06-30.
What is ACTU's EPS (earnings per share)?
ACTUATE THERAPEUTICS, INC. (ACTU)'s trailing twelve month EPS is $-0.86 as of 2026-06-30.
What is ACTU's ROE (return on equity)?
ACTUATE THERAPEUTICS, INC. (ACTU)'s trailing twelve month Return on Equity (ROE) is 2457.58% as of 2026-06-30.
What is ACTU's ROA (return on assets)?
ACTUATE THERAPEUTICS, INC. (ACTU)'s trailing twelve month Return on Assets (ROA) is -336.18% as of 2026-06-30.
What is ACTU's EV/EBITDA?
ACTUATE THERAPEUTICS, INC. (ACTU)'s trailing twelve month EV/EBITDA is -1.55x as of 2026-06-30.